Background: Diabetic macular edema (DME) is a leading cause of visual impairment and its treatment is a public health challenge. Antiangiogenic agents are the gold standard treatment, but they are not ideal, and subthreshold laser (SL) is a viable and promising treatment in certain cases. The purpose of this study was to evaluate its usefulness in a real-world environment